The global chronic pelvic pain treatment market was valued at USD 5.7 billion in 2021. The market is projected to expand at a CAGR of 3.6% from 2022 to 2031, surpassing USD 8 billion by the end of 2031. Increasing incidence of conditions such as endometriosis, interstitial cystitis, pelvic inflammatory disease, irritable bowel syndrome, and musculoskeletal disorders is driving market growth...